Mannheim, January 2014 – A dossier for an EU Art 13.5 claim was filed to show the link between oligofructose and improved blood glucose response after intake. The dossier submitted to EFSA was based on several studies including newly developed science, and shows that oligofructose has a significant part to play in the area of glycaemic control.
EFSA’s positive evaluation allows the approval by the Commission, the Member States and the European Parliament within the health claim procedure.